 Both Cosopt and Xalatan plus Timoptic will significantly lower IOP, however only Cosopt will demonstrate positive hemodynamic effects. The clinical significance of this will be investigated by examining the ophthalmic and short posterior ciliary arteries to determine the blood supply to the optic nerve head, the site of damage in glaucoma 